Featured Bioprocessing Editorial
-
Ramping Up GMP-Compliant CAR-NK Manufacturing At Scale With iPSCs
4/15/2025
The ability to produce billions of NK cells in a single production run represents a transformative shift in the economics and logistics of cell therapy.
-
Pharmaceutical Sovereignty: The Resilience We Cannot Outsource
4/15/2025
Pharmaceutical sovereignty is no longer a theoretical concern. Sovereignty in this context does not imply isolation, but rather strategic resilience: building robust national and regional capabilities that ensure security while enabling global collaboration.
-
How AI Is A Game-Changer For Auditing Compliance And Efficiency
4/9/2025
In the life sciences, audits have long been bogged down by repetitive tasks. AI is changing the way auditors operate, making compliance more seamless than ever.
-
March 2025 — CDMO Opportunities And Threats Report
4/8/2025
Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections.
-
A Closer Look At Buffer Recycling For More Sustainable Bioprocessing
4/8/2025
Recognizing the unexplored potential to save resources, one researcher realized consumption reduction of up to 50% during a key phase of downstream processing.
-
4 Key Solid Tumor Therapy Objectives iPSCs Can Help Achieve
4/4/2025
Induced pluripotent stem cells offer some key biologic, technical, and financial advantages over more established PBMC-derived therapies.
-
Struggling With GxP Systems? There's A DAP For That
4/2/2025
A typical life sciences enterprise now has 500+ software applications. A digital adoption platform (DAP) is an overlay to help with user adoption, like an advanced version of the MS Word "paperclip" assistant.
-
Risk Management Planning: Be Prepared When Disaster Strikes
4/1/2025
Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more.
-
AI Model Cards Make Function And Risk Easier To Understand
3/31/2025
AI doesn’t follow predefined logic like traditional software. Here's a tool, including a downloadable template, to answer critical compliance questions quickly.
-
Amgen's Deep Learning Approach To Vial Inspection
3/31/2025
The company is testing how artificial intelligence can help bring down the number of false rejections caused by factors like glare on the glass or bubbles in the vial.